Seeking Alpha

Myriad Genetics (MYGN +3.3%) moves up this morning after Goldman upgraded shares to Buy with a...

Myriad Genetics (MYGN +3.3%) moves up this morning after Goldman upgraded shares to Buy with a price target of $29. The firm says reimbursement concerns are overdone, plus the stock should gain added traction from the strength of its pipeline and a potential new dividend.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|